There are many unavoidable costs in the current pandemic; all the more reason to avoid actions that add to costs for traders and consumers. Chief among these is the need to avoid export restrictions on essential goods, such as medical equipment and, especially, food products. Currently, more than 60 countries3 have restricted exports of essential goods and increasingly agriculture and food products.
The lesson of the food price crisis of 2007-08 is that export restrictions are a recipe for self-inflicted harm, undermining food security for everyone. Experience has shown that export restrictions temporarily lower domestic prices and raise availability, but they also discourage domestic production and so any benefit tends to be short-lived. Critically, by diverting supplies from world markets, they put upward pressure on international prices, which harms other countries – in particular those most dependent on international markets for food. Export restrictions risk undermining confidence in international markets and can precipitate hoarding and panic buying, further accentuating problems in import-dependent countries. Ultimately, nobody benefits.
There is currently no supply problem in global agriculture and food markets; indeed, at present, stocks are strong and prices look set to stay low. However, if governments engage in export restrictions or if individuals, firms or countries engage in panic buying or hoarding there is a risk of creating an avoidable problem now.
While there is not an immediate threat to global supplies of basic foodstuffs, there is the potential for specific food supply chains to be severely disrupted, including from lack of seasonal workers for planting or harvesting key crops, logistics constraints, and additional SPS and technical measures. Vigilance will be required to ensure that crisis- or policy-induced risk factors do not cause disruptions in supply, in particular if the containment measures related to COVID-19 are long-lived.
The global market situation for medical supplies is very different; there is a critical need to increase the overall global supply of essential medical supplies for combatting COVID-19 such as ventilators and masks. Governments need to invest urgently in boosting production capacity, including in co-operation with the private sector, for local, regional and global markets.
Some governments are taking measures designed to ensure supply for their own population that have the effect of limiting supply for others. Export restrictions often take the form of special licensing requirements or outright bans on the export of certain products. Other measures include guaranteed purchase or requisitioning of goods. These are difficult issues. While governments rightly are concerned to protect their own populations, the effect on other countries – and thus on global efforts to contain the virus and prevent damaging second- or third-wave recurrences – can be severe.
Some countries are not able to produce their own medical supplies in sufficient quantities – or cost effectively. This is especially the case as the virus starts to take hold in lower income countries, where the priority for limited health budgets should not be building domestic manufacturing capacity. For these countries – as has been the case for others that have experienced the virus to date – trade is essential.
Indeed, areas already isolated due to the virus would have been worse off if they had to rely on the local economy to guarantee supplies of medical equipment, food and other necessities and even those countries with production capacity in medical equipment have struggled to meet demand. In the height of COVID-19 outbreaks, even countries with significant manufacturing capacity may not be able to fully utilise it due to labour shortages, or mobility restrictions. Moreover, even domestic manufacture of equipment can rely on imported inputs; the danger of beggar-thy-neighbour policies is that you are also your neighbour’s neighbour.
But if countries are to avoid these policies, they need to be sure that global markets will indeed supply the needed goods. Transparency and global dialogue and co-operation are essential in building the confidence in global supply. If export restrictions on medical supplies cannot be avoided entirely in the current political context, agreements to place strict conditions on their temporary use are vital.
More broadly, to maintain confidence in global markets and co-operation, there is a need to avoid further escalation in ongoing trade tensions. With firms rocked by the collapse in demand and the ongoing uncertainty regarding the duration and severity of COVID-19 and associated containment measures, now is also not the time to impose further costs, including through unnecessary policy uncertainty. Imposing additional costs on firms and consumers through tariffs not only causes hardship for those already suffering from lost income due to the crisis, but also risks increasing the size of the government assistance needed to support those same firms and consumers. A positive step in boosting confidence and reducing burdens would be for governments to commit not to impose new tariffs or trade restrictive measures.
While trade was one of the first victims of the global economic crisis in 2008, new trade restricting measures affected only about 1% of world imports. At that time, G20 leaders committed to refrain from protectionist measures and to uphold the rules-based trading system, and WTO trade rules created some certainty for businesses and stabilised the system by placing a ceiling on tariff measures. While there are some differences, as well as similarities, in the current crisis (see Box), the uncertain economic environment going into today’s crisis increases the need for a commitment to rules-based trade.